Sources Drugs.com: Information about Zepbound Drugs.com: Information about Mounjaro FDA: Zepbound FDA Label FDA: Mounjaro FDA Label NIH: Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity NIH: Efficacy and Safety of Once-Weekly Tirzepatide for Weight Management Compared to Placebo Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice
A study published this past October, for instance, estimated that higher uptake of GLP-1 drugs could prevent 42,000 deaths annually in the U.S
It targets the same two receptors as Mounjaro, GLP-1 and GIP, but adds a third: the glucagon receptor
It allows your body-fat to more easily enter (permeate) your muscle tissue to be burned as fuel energy
Semaglutide (weekly injectable) Dosing frequency: Once weekly, same day each week Half-life: approximately 7 days (165 to 184 hours) Peak concentration: 1 to 3 days after injection Recommended timing approach: Most flexible of all GLP-1 formulations due to the long half-life
Eating disorders can lead to serious health complications including heart and kidney problems, and can be life-threatening if not treated properly
